On November 16, 2020, OncoZenge AB announced that the company has secured financing totaling approximately SEK 70 million prior to the special listing on the Nasdaq First North Growth Market, where the first day for trading is expected to be February 12, 2021.

More information about the Rights issue including prospectus and Q&A are available here

Contact information for investors:

Pirkko Tamsen, CEO

Subscribe to press releases & financial reports

Please enter your email